• Profile
Close

Pseudomonas aeruginosa eradication therapy and risk of acquiring Aspergillus in young children with cystic fibrosis

Thorax Jun 20, 2019

Harun SN, et al. - Via cross-sectional analysis of data from the Australasian Cystic Fibrosis Bronchoalveolar Lavage study, researchers focused on the risk and explanatory factors of acquiring Aspergillus in children with cystic fibrosis (CF) by age 5 years. For the first P. aeruginosa positive culture and for the first Aspergillus positive culture, the median (IQR) age was 2.38 (1.32-3.79) years and 3.69 (1.68-4.74) years, respectively. Following first year of study entry, alterations in the risk of P. aeruginosa and Aspergillus events were evident with time. Risk for P. aeruginosa was lower following the completion P. aeruginosa eradication, but it increased for Aspergillus events. Increased risk of acquiring Aspergillus was reported in relation to completing P. aeruginosa eradication therapy and previous Aspergillus events in young children with CF.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay